My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 403

    1.

    Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis.

    Seidenfeld J, Samson DJ, Hasselblad V, Aronson N, Albertsen PC, Bennett CL, Wilt TJ.

    Ann Intern Med. 2000 Apr 4;132(7):566-77. Erratum in: Ann Intern Med. 2005 Nov 15;143(10):764-5. PMID: 10744594 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Relative effectiveness and cost-effectiveness of methods of androgen suppression in the treatment of advanced prostate cancer.

    Seidenfeld J, Samson DJ, Aronson N, Albertson PC, Bayoumi AM, Bennett C, Brown A, Garber A, Gere M, Hasselblad V, Wilt T, Ziegler K.

    Evid Rep Technol Assess (Summ). 1999 May;(4):i-x, 1-246, I1-36, passim. Review.PMID: 11098244 [PubMed - indexed for MEDLINE]Related articles

    3.

    Systematic review and meta-analysis of monotherapy compared with combined androgen blockade for patients with advanced prostate carcinoma.

    Samson DJ, Seidenfeld J, Schmitt B, Hasselblad V, Albertsen PC, Bennett CL, Wilt TJ, Aronson N.

    Cancer. 2002 Jul 15;95(2):361-76. Review.PMID: 12124837 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Early versus deferred androgen suppression in the treatment of advanced prostatic cancer.

    Nair B, Wilt T, MacDonald R, Rutks I.

    Cochrane Database Syst Rev. 2002;(1):CD003506. Review.PMID: 11869665 [PubMed - indexed for MEDLINE]Related articles

    5.

    Cost-effectiveness of androgen suppression therapies in advanced prostate cancer.

    Bayoumi AM, Brown AD, Garber AM.

    J Natl Cancer Inst. 2000 Nov 1;92(21):1731-9.PMID: 11058616 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    Maximum androgen blockade in advanced prostate cancer: a meta-analysis of published randomized controlled trials using nonsteroidal antiandrogens.

    Caubet JF, Tosteson TD, Dong EW, Naylon EM, Whiting GW, Ernstoff MS, Ross SD.

    Urology. 1997 Jan;49(1):71-8.PMID: 9000189 [PubMed - indexed for MEDLINE]Related articles

    7.

    Maximal androgen blockade for advanced prostate cancer.

    Schmitt B, Bennett C, Seidenfeld J, Samson D, Wilt T.

    Cochrane Database Syst Rev. 2000;(2):CD001526. Review.PMID: 10796804 [PubMed - indexed for MEDLINE]Related articles

    8.

    Luteinizing hormone-releasing hormone agonists in the treatment of prostate cancer: a review of their discovery, development, and place in therapy.

    Moreau JP, Delavault P, Blumberg J.

    Clin Ther. 2006 Oct;28(10):1485-508. Review. Erratum in: Clin Ther. 2006 Nov;28(11):1970. PMID: 17157109 [PubMed - indexed for MEDLINE]Related articles

    9.

    Combined androgen blockade with nonsteroidal antiandrogens for advanced prostate cancer: a systematic review.

    Schmitt B, Wilt TJ, Schellhammer PF, DeMasi V, Sartor O, Crawford ED, Bennett CL.

    Urology. 2001 Apr;57(4):727-32.PMID: 11306391 [PubMed - indexed for MEDLINE]Related articles

    10.

    Luteinizing hormone-releasing hormone agonists in the treatment of men with prostate cancer: timing, alternatives, and the 1-year implant.

    Marks LS.

    Urology. 2003 Dec 22;62(6 Suppl 1):36-42. Review.PMID: 14706507 [PubMed - indexed for MEDLINE]Related articles

    11.

    [Cost-utility analysis of androgen ablation therapy in metastatic prostate cancer]

    Fujikawa K, Awakura Y, Okabe T, Watanabe R, Nishimura S.

    Nippon Hinyokika Gakkai Zasshi. 2003 May;94(4):503-11; discussion 511-2. Japanese. PMID: 12795165 [PubMed - indexed for MEDLINE]Related articles

    12.

    Evolution of therapeutic approaches with luteinizing hormone-releasing hormone agonists in 2003.

    Moul JW, Fowler JE Jr.

    Urology. 2003 Dec 22;62(6 Suppl 1):20-8.PMID: 14706505 [PubMed - indexed for MEDLINE]Related articles

    13.

    Androgen-deprivation therapy as primary treatment for localized prostate cancer: data from Cancer of the Prostate Strategic Urologic Research Endeavor (CaPSURE).

    Kawakami J, Cowan JE, Elkin EP, Latini DM, DuChane J, Carroll PR; CaPSURE Investigators.

    Cancer. 2006 Apr 15;106(8):1708-14.PMID: 16544313 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Endocrine treatment of prostate cancer.

    Tammela T.

    J Steroid Biochem Mol Biol. 2004 Nov;92(4):287-95. Epub 2004 Dec 31. Review.PMID: 15663992 [PubMed - indexed for MEDLINE]Related articles

    15.

    Quality-of-life outcomes after primary androgen deprivation therapy: results from the Prostate Cancer Outcomes Study.

    Potosky AL, Knopf K, Clegg LX, Albertsen PC, Stanford JL, Hamilton AS, Gilliland FD, Eley JW, Stephenson RA, Hoffman RM.

    J Clin Oncol. 2001 Sep 1;19(17):3750-7.PMID: 11533098 [PubMed - indexed for MEDLINE]Related articles

    16.

    Neo-adjuvant and adjuvant hormone therapy for localised and locally advanced prostate cancer.

    Kumar S, Shelley M, Harrison C, Coles B, Wilt TJ, Mason MD.

    Cochrane Database Syst Rev. 2006 Oct 18;(4):CD006019. Review.PMID: 17054269 [PubMed - indexed for MEDLINE]Related articles

    17.

    Adjuvant hormone therapy after radiation or surgery for localized or locally advanced prostate cancer.

    See WA.

    Curr Treat Options Oncol. 2003 Oct;4(5):351-62. Review.PMID: 12941195 [PubMed - indexed for MEDLINE]Related articles

    18.

    Hormonal therapy of prostate cancer.

    Debruyne F.

    Semin Urol Oncol. 2002 Aug;20(3 Suppl 1):4-9. Review.PMID: 12198632 [PubMed - indexed for MEDLINE]Related articles

    19.

    Intermittent versus continuous androgen suppression for prostatic cancer.

    Conti PD, Atallah AN, Arruda H, Soares BG, El Dib RP, Wilt TJ.

    Cochrane Database Syst Rev. 2007 Oct 17;(4):CD005009. Review.PMID: 17943832 [PubMed - indexed for MEDLINE]Related articles

    20.

    Advantages of the combination therapy in previously untreated and treated patients with advanced prostate cancer.

    Labrie F, Dupont A, Giguere M, Borsanyi JP, Belanger A, Lacourciere Y, Emond J, Monfette G.

    J Steroid Biochem. 1986 Nov;25(5B):877-83.PMID: 3100871 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity